Integra LifeSciences Holdings Corporation (IART) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Integra LifeSciences Holdings Corporation (IART) - Medical Equipment - Deals and Alliances Profile

Integra LifeSciences Holdings Corporation (IART) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Integra LifeSciences Holdings Corporation (IART) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
64 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Integra LifeSciences Holdings Corporation (Integra) is a medical technology company. Integras orthopedics products comprise specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. The companys neurosurgery products consist of ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra solutions find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices.

Integra LifeSciences Holdings Corporation (IART) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the

  
Source:
Document ID
GDME717D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Integra LifeSciences Holdings Corporation, Medical Equipment, Deals By Year, 2010 to YTD 201652
Integra LifeSciences Holdings Corporation, Medical Equipment Deals By Type, 2010 to YTD 201671
Integra LifeSciences Holdings Corporation, Medical Equipment, Deals By Region, 2010 to YTD 201681
Integra LifeSciences Holdings Corporation, Medical Equipment, Deals By Market, 2010 to YTD 201691
Integra LifeSciences Holdings Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016102
Integra LifeSciences Holdings Corporation, Medical Equipment, Deal Details1226
  Asset Purchase121
    Integra LifeSciences Acquires Ankle and Toe Replacement Products from Tornier for USD6 Million122
    Integra LifeSciences Acquires Ankle Replacement and Silastic Toe Replacement Products from Tornier142
    Integra LifeSciences Acquires Foot and Ankle Product Portfolio from Metasurg161
    Integra LifeSciences Acquires Medtronic MicroFrance and Certain Assets from Medtronic172
    Integra LifeSciences Completes Acquisition Of Confluent Surgical Product Line From Covidien For US$265 Million191
    Integra LifeSciences Holdings Acquires Extremity Reconstruction Business From Culley Investments For US$1.7201
    Welch Allyn Completes Sale Of Surgical Lighting Product Lines To Integra LifeSciences Holdings211
  Partnerships221
    Integra LifeSciences Holdings Enters Into Licensing Agreement With Stout Medical221
    Integra LifeSciences Enters into Agreement with AlloSource231
    Integra LifeSciences Enters into Agreement with Vomaris Wound Care241
    Integra LifeSciences Enters Into Distribution Agreement With aap Implantate For Stainless Headed Compression Screw System251
    Medistim Enters Into Distribution Agreement With Integra LifeSciences261
  Equity Offering271
    Integra LifeSciences Raises USD220 Million in Public Offering of Shares271
    Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million282
    Integra LifeSciences Completes Public Offering Of Shares For US$161 Million302
  Debt Offering321
    Integra LifeSciences Holdings Completes Private Placement Of Convertible Senior Notes Due 2016 For US$230 Million322
  Acquisition341
    Integra LifeSciences Acquires TEI Medical and TEI Biosciences for USD312 Million342
    Integra LifeSciences Acquires Ascension Orthopedics For US$65 Million361
    Integra LifeSciences Acquires SeaSpine371
Integra LifeSciences Holdings Corporation - Key Competitors381
Key Employees391
Locations And Subsidiaries405
  Head Office401
  Other Locations &Subsidiaries405
Recent Developments451
Strategy And Business Planning451
Sep 01, 2015: Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion451
Jul 01, 2015: Integra LifeSciences Completes Spin-Off of SeaSpine461
Apr 01, 2015: Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine471
Financial Announcements481
Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results482
Apr 27, 2016: Integra LifeSciences Reports First Quarter 2016 Financial Results501
Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance512
Nov 03, 2015: Integra LifeSciences Reports Third Quarter 2015 Financial Results531
Jul 30, 2015: Integra LifeSciences Reports Second Quarter 2015 Financial Results542
Apr 30, 2015: Integra LifeSciences Reports First Quarter 2015 Financial Results562
Feb 24, 2015: Integra LifeSciences Reports Fourth Quarter 2014 Financial Results581
Corporate Communications591
Apr 30, 2015: Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine591
Legal and Regulatory601
Jan 20, 2015: Integra LifeSciences Announces Resolution of Warning Letter Related to Its Manufacturing Facility in Anasco, Puerto Rico601
Product News611
Feb 03, 2015: Integra LifeSciences Announces Submission of a Premarket Approval Supplement Application for the Treatment of Diabetic Foot Ulcers611
Jan 21, 2015: Integra LifeSciences Launches Integra Reinforcement Matrix621
Other Significant Developments631
Feb 25, 2016: Integra LifeSciences Announces Service Alliance Agreement With PREZIO Health631
Appendix641
  Methodology641
  About GlobalData641
  Contact Us641
  Disclaimer641

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Integra LifeSciences Holdings Corporation (IART) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Integra-LifeSciences-Holdings-Corporation-IART-Medical-Equipment-Deals-and-Alliances-Profile-2148-17586>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Integra LifeSciences Holdings Corporation (IART) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Integra-LifeSciences-Holdings-Corporation-IART-Medical-Equipment-Deals-and-Alliances-Profile-2148-17586>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research